47th week of 2014 patent applcation highlights part 53 |
Patent application number | Title | Published |
20140343290 | PROCESS FOR THE PREPARATION OF ATAZANAVIR OR ITS BISULFATE SALT - The present invention relates to an improved process for the preparation of atazanavir bisulfate, an inhibitor of retroviral aspartate protease. The process of the present invention comprises conversion of 1,1-dimethylethyl[(2S,3R)-4-chloro-3-hydroxy-phenylbutan-2-yl]carbamate (Formula II) into 1-[4-(pyridine-2-yl)-phenyl]-4(S)-5 hydroxy-2-N-tert-butoxycarbonylamino-5(S)—N—(N-methoxycarbonyl-(L)-tert-leucyl)amino-6-phenyl-2-azahexane (Formula VII) without isolating intermediate compounds formed therein, followed by its subsequent conversion to atazanavir or its bisulfate salt. | 2014-11-20 |
20140343291 | SILICON-CONTAINING BIANTHRACENE DERIVATIVE, PRODUCTION PROCESS AND USE THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE - The invention provides a silicon-containing bianthracene derivative, a production process and use thereof, and an organic electroluminescent device. The invention belongs to the technical field of organic electroluminescence, and can give a blue light-emitting material being able to form a dense film. The silicon-containing bianthracene derivative has a molecular structure of the following general formula, wherein R group represents an aryl group having a carbon atom number of 6-14, an aromatic heterocyclic group having a carbon atom number of 8-18, a fused-ring aromatic group having a carbon atom number of 9-15, a fluorenyl group, or a triarylamino group. The silicon-containing bianthracene derivative mentioned in the invention can be used in an organic electroluminescent device. | 2014-11-20 |
20140343292 | PROCESS FOR THE PREPARATION OF A THIOPRECURSOR FOR STATINS - The present invention relates to a process for the preparation of a precursor for the synthesis of hexanoic acid derived statins and to the use of said precursor in the manufacture of a medicament. | 2014-11-20 |
20140343293 | 1, 2, 4-TRIAZOLE-BASED DERIVATIVE, PRODUCTION PROCESS AND USE THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE - The invention provides a 1,2,4-triazole-based derivative, a production process and use thereof, and an organic electroluminescent device. The invention belongs to the technical field of organic electroluminescence, and can give a blue light-emitting material having a higher luminescence efficiency. The 1,2,4-triazole-based derivative has a molecular structure of the following general formula, wherein A group represents an aromatic heterocyclic group having a carbon atom number of 8-18, a fused-ring aromatic group having a carbon atom number of 9-15, a fluorenyl group, or a triarylamino group. The 1,2,4-triazole-based derivative mentioned in the invention can be used in organic electroluminescent device. | 2014-11-20 |
20140343294 | PHARMACEUTICAL COMPOUNDS - Compounds of formula (I): | 2014-11-20 |
20140343295 | NOVEL 6-PYRAZOLYLAMIDO-3-SUBSTITUTED AZABICYCLO[3.1.0]HEXANE COMPOUNDS AS CALCIUM CHANNEL INHIBITORS - The present invention relates to a 6-pyrazolylamido-3-substituted azabicyclo[3.1.0]hexane derivatives useful as calcium channel blockers, pharmaceutically acceptable salts thereof and medical use of the calcium channel inhibiting effect of the compounds for treatment of diseases. | 2014-11-20 |
20140343296 | Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isoben- zofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes - A new process for the manufacture of iodinated xanthenes in high purity includes a cyclization step followed by an iodination step. No extraction, chromatographic or solvent concentration steps are required, and the intermediate as well as final compounds are isolated via filtration or similar means. The process requires a single organic solvent, and the steps are completed at temperatures below 100° C. The exclusion of chloride ions, of chloride free-radicals, hypochlorite ions, or hypochlorous acid as reagents or from reagents that may generate these species in situ in the presence of oxidants, prevents undesirable impurity formation. Several new compounds have been conceived and isolated using these methods. These new compounds are also formed into new medicaments. | 2014-11-20 |
20140343297 | 3-(5-METHYL-2-OXO-L, 3-DIOXOL-4-YL) METHYLOXY-2- TRANS-[(4-CHLORO PHENYL) CYCLOHEXYL][1,4]NAPHTHAQUINONE-ATOVAQUONE PRODRUG - The present invention relates to atovaquone prodrug compound of formula (I). Accordingly, present invention provides a process involving condensation of Atovaquone (II) with 5-methyl-4-chloromethyl dioxalone (III) in suitable solvent system and optionally followed by distillation and crystallization to provide Atovaquone prodrug compound of formula (I) in high yields, purity, and suitable for large-scale manufacture. | 2014-11-20 |
20140343298 | METHOD FOR PRODUCING GLYCOLIDE - A method for producing glycolide comprises depolymerizing a glycolic acid oligomer in the presence of a phenol-based antioxidant. | 2014-11-20 |
20140343299 | PROCESS FOR THE PREPARATION OF TRAVOPROST - The invention relates to a process for the preparation of travoprost of formula (I), comprising that, the compound of formula (II), is stereo selectively reduced, the resulting compound of formula (III), is if desired crystallized, the lactone group of the compound of formula (III) is reduced, the p-phenyl-benzoyl protecting group of the thus obtained compound of formula (IV), is removed, the resulting triol of formula (V), is, if desired after crystallization, transformed by Wittig reaction into the acid of formula (VI), which is then esterified. | 2014-11-20 |
20140343300 | Process For The Production Of Trioxane From Aqueous Formaldehyde Sources - The present invention relates to a process for producing cyclic acetal comprising i) preparing a liquid reaction mixture comprising a) a formaldehyde source, b) an aprotic compound and c) a catalyst; wherein the total amount of protic compounds is less than 40 wt.-%, based on the total weight of the reaction mixture; and ii) converting the formaldehyde source into cyclic acetals. | 2014-11-20 |
20140343301 | Process for Producing A Cyclic Acetal - The present invention relates to a process for producing cyclic acetal comprising i) preparing a reaction mixture comprising a) a formaldehyde source in a liquid medium and b) a catalyst; ii) converting the formaldehyde source into cyclic acetals, wherein the final conversion of said formaldehyde source to said cyclic acetal is greater than 10% on basis of the initial formaldehyde source. | 2014-11-20 |
20140343302 | Process for Recycling Polyacetals - A process for recycling polyoxymethylene polymers is disclosed. A polyoyxmethylene polymer is at least partially dissolved in an aprotic compound. The resulting solution or suspension (liquid mixture) is then contacted with a catalyst which causes the polyoxymethylene polymer to be converted into a cyclic acetal. The cyclic acetal can be separated, collected and used in other processes. In one embodiment, the cyclic acetal may be used to produce a polyoxymethylene polymer. | 2014-11-20 |
20140343303 | NOVEL EPIGALLOCATECHIN GALLATE TETRAMER AND VASCULAR ENDOTHELIAL FUNCTION IMPROVING AGENT CONTAINING THE SAME - Providing a compound capable of continuously taking and having a vascular endothelial function improving effect by enhancing NO function from the vascular endothelial cells. | 2014-11-20 |
20140343304 | METHOD FOR MANUFACTURING COMPOUNDS INCLUDING NITRILE FUNCTIONS - The present invention relates to the manufacture of compounds of general formula I or III including nitrile functions. Specifically, the invention relates to the manufacture of compounds including nitrile functions from compounds which include carboxyl functions and which are advantageously of natural and renewable origin. | 2014-11-20 |
20140343305 | PROCESS FOR PRODUCING BOTH BIOBASED SUCCINIC ACID AND 2,5-FURANDICARBOXYLIC ACID - A process is provided for carrying out an oxidation on a feed including levulinic acid and/or a levulinic acid oxidation precursor to succinic acid, one or more furanic oxidation precursors of 2,5-furandicarboxylic acid and a catalytically effective combination of cobalt, manganese, and bromide components for catalyzing the oxidation of the levulinic acid component and of the one or more furanic oxidation precursors to produce both succinic acid and 2,5-furandicarboxylic acid products, which process comprises supplying the feed to a reactor vessel, supplying an oxidant, reacting the levulinic acid component and the one or more furanic oxidation precursors with the oxidant to produce both succinic acid and 2,5-furandicarboxylic acid (FDCA) and then recovering the succinic acid and FDCA products. A crude dehydration product from the dehydration of fructose, glucose or both, including 5-hydroxymethylfurfural, can be directly oxidized by the process to produce 2,5-furandicarboxylic acid and succinic acid. | 2014-11-20 |
20140343306 | CARRIER TREATMENT TO IMPROVE CATALYTIC PERFORMANCE OF AN ETHYLENE OXIDE CATALYST - A method for lowering the sodium content of different carriers which may have different physical properties as well as varying degrees of sodium is provided. The method, which lowers the sodium content from the surface, subsurface as well as the binding layer of the carrier, includes contacting a carrier with water. A rinse solution is recovered from the contacting. The rinse solution includes leached sodium from the carrier. The sodium content in the rinse solution is then determined. The contacting, recovering and determining are repeated until a steady state in the sodium content is achieved. | 2014-11-20 |
20140343307 | CARRIER FOR ETHYLENE OXIDE CATALYSTS - A carrier for an ethylene epoxidation catalyst is provided that includes an alumina first component and a mixed metal oxide of alumina second component. The mixed metal oxide of alumina second component comprises a corundum lattice structure having a plurality of O—Al—O bonds, wherein an Al atom of at least one O—Al—O bond of the plurality of O—Al—O bonds, but not all of the plurality of O—Al—O bonds, is replaced with a divalent or trivalent transition metal selected from the group consisting of scandium (Sc), titanium (Ti), vanadium (V), chromium (Cr), manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni) copper (Cu), and zinc (Zn). A catalyst containing the carrier, as well as a process for the epoxidation of ethylene using the catalyst are also disclosed. | 2014-11-20 |
20140343308 | SILVER-BASED ETHYLENE OXIDE CATALYST HAVING REDUCED SODIUM CONTENT - A silver-based ethylene oxide catalyst that can be used in the vapor phase conversion of ethylene to ethylene oxide in the presence of oxygen is provided that includes a carrier; a catalytic effective amount of silver; and a promoting amount of at least one promoter, wherein the catalyst has a surface sodium content of 100 ppm or less. | 2014-11-20 |
20140343309 | Supercritical Fluid Extraction Process of Kenaf Seeds - The present invention provides a supercritical fluid extraction (SFE) process for extracting oil of kenaf seed ( | 2014-11-20 |
20140343310 | Method for Producing Vinyl Esters - The present invention relates to a continuous, catalytic process for preparing a vinyl ester of the formula R—C(O)O—CH═CH | 2014-11-20 |
20140343311 | ACTIVATION OF METAL SALTS WITH SILYLHYDRIDES AND THEIR USE IN HYDROSILYLATION REACTIONS - The invention relates generally to transition metal salts, more specifically to iron, nickel, cobalt, manganese and ruthenium salts, activated with silylhydrides, and their use as efficient hydrosilylation catalysts. | 2014-11-20 |
20140343312 | Novel method to manufacture surface active compounds such as sulfate betaine - The present invention relates generally to novel methods of preparing compounds such as sulfate betaines by reacting an amine with a cyclic (poly)glycerol sulphate (CGS) compound and the compound such as sulfate betaine products obtained by using the same. | 2014-11-20 |
20140343313 | METHOD FOR MAKING ORGANODIPHOSPHITES FROM PHOSPHOROCHLORIDITES CHARACTERIZED BY MEASURING SIDE-PRODUCT LEVELS TO DETERMINE FURTHER ADDITIONS - Claimed is a process for producing a phosphorus-containing ligand, preferably a diphosphite ligand structure (DLS) such as structure I. The method includes contacting a phosphorochloridite (structure II) with a compound having the structure X—OH (which can be a bisaryl compound), and a tertiary organic amine to provide structure I′ and as preferred embodiment structure I. | 2014-11-20 |
20140343314 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF - The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. | 2014-11-20 |
20140343315 | Modulators of ATP-Binding Cassette Transporters - The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators. | 2014-11-20 |
20140343316 | Esters Of Structurally Symmetric Alkoxylated Polyols And Applications Thereof - In one aspect, compositions are described herein. In some embodiments, a composition comprises an ester reaction product of a structurally symmetric alkoxylated polyol and a carboxylic acid or carboxylic acid equivalent. In some embodiments, the structurally symmetric alkoxylated polyol comprises an alkoxylated pentaerythritol, dipentaerythritol, tripentaerythritol, higher oligomer of a pentaerythritol, or a combination thereof. | 2014-11-20 |
20140343317 | EXTRACTION OF CARBOXYLIC ACIDS FROM A DILUTE AQUEOUS STREAM - A process for removing free carboxylic acid from an aqueous solution including a mass fraction of less than 1% wt of the free carboxylic acid. The process includes the steps of: (a) contacting the aqueous solution with a depleted solvent including a polyamine extractant to obtain an extract enriched in free carboxylic acid and a raffinate having a reduced free carboxylic acid content; and (b) separating the raffinate from the extract, wherein the polyamine extractant is a compound containing at least two nitrogen atoms, and at least one double bond between a nitrogen atom and a carbon atom. | 2014-11-20 |
20140343318 | PROCESS FOR PREPARING VINYLIDENECARBOXYLIC ACID (ESTER)S BY REACTION OF FORMALDEHYDE WITH ALKYLCARBOXYLIC ACID (ESTER)S - Process for preparing a vinylidenecarboxylic acid or ester thereof, wherein a reaction gas comprising gaseous formaldehyde, molecular oxygen and an alkycarboxylic acid or ester thereof is brought into contact with a solid catalyst whose active composition comprises a vanadium-phosphorus oxide having an average oxidation state of vanadium of from +4.40 to +5.0 to give a product gas comprising the vinylidenecarboxylic acid or ester thereof. | 2014-11-20 |
20140343319 | PROCESS FOR PREPARING ACRYLIC ACID WITH HIGH SPACE-TIME YIELD - In a process for preparing acrylic acid, a reaction gas which comprises a gaseous formaldehyde source and gaseous acetic acid and in which the partial pressure of the formaldehyde source, calculated as formaldehyde equivalents, is at least 85 mbar and in which the molar ratio of the acetic acid to the formaldehyde source, calculated as formaldehyde equivalents, is at least 1 is contacted with a solid condensation catalyst. The space-time yield can be enhanced significantly by increasing the partial pressure of the reactants. The space-time yield remains high even after prolonged process duration. | 2014-11-20 |
20140343320 | DEVICE AND METHOD FOR SEPARATING OFF WATER AND RECOVERING A CARBOXYLIC ACID FROM REACTOR DISCHARGE DURING AN AROMATIC COMPOUND OXIDATION REACTION USING ENERGY DONATING COUPLED DISTILLATION - Provided is a method of separating off reaction product water and recovering a carboxylic acid used as a solvent in a reactor from a reactor discharge during oxidation of an aromatic compound, and more particularly, a method of separating off reaction product water and recovering a carboxylic acid used as a solvent in a reactor from a reactor discharge during oxidation of an aromatic compound, wherein during the oxidation of the aromatic compound, the reactor discharge is led into two or more dehydration towers having different operating pressures such that a condenser of one dehydration tower operates as a reboiler of another dehydration tower, thereby remarkably reducing energy consumption. | 2014-11-20 |
20140343321 | Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism - The invention relates to plasminogen activator-1 (PAI-1) inhibitor compounds and uses thereof in the treatment of any disease or condition associated with elevated PAI-1. The invention includes, but is not limited to, the use of such compounds to modulate lipid metabolism and treat conditions associated with elevated PAI-1, cholesterol, or lipid levels. | 2014-11-20 |
20140343322 | PROCESS FOR PREPARING LEVOMILNACIPRAN HCL - The invention relates to one-pot process for preparing (1S,2R)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2-aminomethylcyclopropane of formula (I) comprising the step of reacting (1S,2R)-N,N-diethyl-2-(hydroxymethyl)-1-phenylcyclopropanecarboxamide successively with the following reactants 1) triethyl orthoformate and methanesulfonic acid or triethylamine and methanesulfonyl chloride, 2) a phthalimidating agent, 3) aqueous EtNH | 2014-11-20 |
20140343323 | PROCESS FOR PRODUCTION OF HEXAMETHYLENEDIAMINE FROM CARBOHYDRATE-CONTAINING MATERIALS AND INTERMEDIATES THEREFOR - Processes are disclosed for the conversion of a carbohydrate source to hexamethylenediamine (HMDA) and to intermediates useful for the production of hexamethylenediamine and other industrial chemicals. HMDA is produced by direct reduction of a furfural substrate to 1,6-hexanediol in the presence of hydrogen and a heterogeneous reduction catalyst comprising Pt or by indirect reduction of a furfural substrate to 1,6-hexanediol wherein 1,2,6-hexanetriol is produced by reduction of the furfural substrate in the presence of hydrogen and a catalyst comprising Pt and 1,2,6-hexanediol is then converted by hydrogenation in the presence of a catalyst comprising Pt to 1,6 hexanediol, each process then proceeding to the production of HMDA by known routes, such as amination of the 1,6 hexanediol. Catalysts useful for the direct and indirect production of 1,6-hexanediol are also disclosed. | 2014-11-20 |
20140343324 | SYNTHETIC MATRIX FOR CONTROLLED CELL INGROWTH AND TISSUE REGENERATION - Biomaterials containing a three-dimensional polymeric network formed from the reaction of a composition containing at least a first synthetic precursor molecule having n nucleophilic groups and a second precursor molecule having m electrophilic groups wherein the sum of n+m is at least five and wherein the sum of the weights of the first and second precursor molecules is in a range from about 8 to about 16% b weight of the composition, preferably from about 10 to about 15%, more preferably from about 12 to about 14.5% by weight of the composition. In one embodiment, the first and second precursor molecules are polyethylene glycols functionalized with nucleophilic and electrophilic groups, respectively. In a preferred embodiment, the nucleophilic groups are amino and/or thiol groups and the electrophilic groups are conjugated, unsaturated groups. The ratio of the equivalent weights of the electrophilic groups (second precursor molecule) and the nucleophilic groups (first precursor molecule) is in the range of between 0.7 and 1.1, more preferably between 0.8 and 1.0. The first and/or second precursor molecule may be covalently bound to one or more molecules selected from the group consisting of cell adhesion peptides, growth factors, and growth factor-like peptides. | 2014-11-20 |
20140343325 | METHOD FOR THE PURPOSE OF A CATALYTIC CONDENSATION OR COUPLING - The invention relates to a method for catalytically condensing organic compounds containing at least one oxo and/or hydroxyl function into CH acidic compounds and/or coupling said organic compounds to the CH acidic compounds in the presence of a catalyst which comprises an active carbon substrate provided with a metal. The method is suitable in particular for generating higher alcohols, aldehydes, ketones, and/or alkanes as well as mixtures thereof. | 2014-11-20 |
20140343326 | FAST CATALYZED HYPOHALOUS OXIDATION OF ALCOHOL GROUPS - An improved process for oxidation of at least one alcohol group of at least one chemical compound to the corresponding carbonyl group. Said process is carried out in the presence of a buffered oxidative hypohalous solution and of a nitroxide oxidation catalyst. It is characteristically carried out within a micro-reactor; the buffered oxidative hypohalous solution being extemporaneously prepared at a buffered pH comprised between 7 and less than 8.5 (7≦pH<8.5). | 2014-11-20 |
20140343327 | JET LOOP REACTOR HAVING NANOFILTRATION - The invention relates to a device for the continuous, homogeneous-catalysis reaction of a liquid with a gas and optionally an additional fluid, wherein the device comprises at least one reactor having an external liquid circulation driven by a pump, and wherein the device has at least one membrane separation stage that preferably holds back the homogeneous catalyst. The aim of the invention is to specify a device that allows homogeneous-catalysis gas/liquid phase reactions, in particular hydroformylations, which operate with membrane separation of the catalyst to be performed economically at an industrially relevant scale. Said aim is achieved in that a jet loop reactor is provided as the reactor, and that the pump and the membrane separation stage are arranged in the same external liquid circuit. | 2014-11-20 |
20140343328 | PROCESSES FOR MAKING MAGNOLOL ANALOGS - Described herein are high yield methods for making magnolol analogs which are 5,5′-dialkyl-bi-phenyl-2,2′-diols. | 2014-11-20 |
20140343329 | PROCESS FOR PREPARING DEODORIZED 1,2-PROPANEDIOL - The present invention relates to a process for preparing deodorized 1,2-propanediol, to the use of the purified propanediol and to an apparatus for performing the process. | 2014-11-20 |
20140343330 | DEHALOGENATION OF TRANS-1-CHLORO-3,3,3-TRIFLUOROPROPENE - The present invention is related to making hydrofluorocarbons (HCFCs), more specifically, 3,3,3-trifluoropropyne (TFP), from trans-1-chloro-3,3,3-trifluoropropene (trans-1233zd) by contacting the trans-1233zd with a base. Preferably, the base is potassium hydroxide or potassium tert-butoxide, which may or may not be dissolved in as solvent. | 2014-11-20 |
20140343331 | PROCESS TO MANUFACTURE 2-CHLORO-1,1,1,2-TETRAFLUOROPROPANE (HCFC-244bb) - The invention relates to a process to produce HCFC-244bb from HCFO-1233xf wherein, in one embodiment, co-feed species HFC-245cb is added to the reaction at a pressure of at least about 100 psig; and in another embodiment it is added to maintain a mole ratio of HFC-245cb to HCFO-1233xf of between about 0.005:1 to about 1:1. The HFC-245cb may be added as recycled by-product of the reaction and/or added as fresh feed. The HFC-245cb provides elevated pressures to the reaction thereby facilitating reactor operation, mixing and HCFC-244bb product removal. Other co-feed species are also disclosed. | 2014-11-20 |
20140343332 | INHIBITORS OF TOP-OF-LINE CORROSION OF PIPELINES CONVEYING CRUDES FROM EXTRACTION OF HYDROCARBONS - A composition for inhibiting corrosion of the upper part (or roof) of a pipeline for conveying wet hydrocarbons, i.e. hydrocarbons comprising a variable amount of water, comprises at least one Amine 1 with vapour pressure greater than or equal to 10 mmHg, and at least one Amine 2 with vapour pressure greater than or equal to 0.1 mmHg and less than 10 mmHg. The use of such a composition, and also to the method of inhibiting top-of-line corrosion employing the inhibitor composition is also disclosed. | 2014-11-20 |
20140343333 | PROCESS FOR CONVERTING A SOLID BIOMASS MATERIAL - A process for converting a solid biomass material comprising: a) providing a solid biomass material; b) contacting a feed comprising the solid biomass material and a petroleum-derived hydrocarbon composition, which petroleum derived hydrocarbon composition has a C7-asphaltenes content of equal to or more than 1.0 wt %, based on the total weight of the petroleum-derived hydrocarbon composition, co-currently with a source of hydrogen in one or more ebullating bed reactors comprising a catalyst at a temperature in the range from 350° C. to 500° C. to produce a reaction product. | 2014-11-20 |
20140343334 | Catalyst with Supplement Component for Hydroprocessing of Bio-feedstock - A process for hydrogenation of oxygen-containing organic products, oil refinery products or mixtures thereof, wherein the process comprises bringing the organic products, oil refinery products, or mixtures thereof into contact with a catalyst according to claim | 2014-11-20 |
20140343335 | System and Method for Reducing Fouling Rate In A Hydrogenation Reactor - Fouling rate inhibition for a hydrogenation reactor. A hydrocarbon hydrogenation method comprises passing a liquid feedstream through a magnetic field to separate magnetically susceptible particles, and introducing the magnetically lean stream into a fixed catalyst bed under hydrogenation conditions to saturate carbon-carbon double bonds in the hydrocarbon. Also, a hydrogenation reactor system comprises a magnetic conditioning zone, an inlet flow path to introduce a magnetically lean stream from the magnetic conditioning zone into a fixed catalyst bed and an outlet flow path from an outlet end of the catalyst bed to withdraw reactor effluent. | 2014-11-20 |
20140343336 | PROCESS FOR THE OXIDATIVE REGENERATION OF A DEACTIVATED CATALYST AND AN APPARATUS THEREFOR - The present invention relates to a process for the oxidative regeneration of a deactivated catalyst comprising providing a catalyst comprising molecular sieve in hydrogen form to a guard zone; passing a regeneration gas stream comprising oxidant through the guard zone to remove part of one or both of any alkali metal ion and alkaline earth metal ion from the regeneration gas stream, to provide a treated regeneration gas stream; providing deactivated catalyst comprising molecular sieve in a regeneration zone, said deactivated catalyst from one or both of an oxygenate to olefin process and an olefin cracking process; regenerating the deactivated catalyst in the regeneration zone with the treated regeneration gas stream to provide regenerated molecular sieve catalyst; wherein said catalyst in said guard zone is one or both of deactivated catalyst comprising molecular sieve in hydrogen form and regenerated catalyst comprising regenerated molecular sieve in hydrogen form. | 2014-11-20 |
20140343337 | CATALYST FOR PRODUCING PARAXYLENE BY CO-CONVERSION OF METHANOL AND/OR DIMETHYL ETHER AND C4 LIQUEFIED GAS, METHOD FOR PREPARING THE SAME AND METHOD FOR USING THE SAME - This application provides a catalyst for producing paraxylene by co-conversion of methanol and/or dimethyl ether and C | 2014-11-20 |
20140343338 | CATALYST RETURN APPARATUS AND PROCESS FOR REACTING A FEEDSTOCK - A catalyst return apparatus is disclosed as well as a riser reactor system comprising the conduit apparatus and a riser reactor, the conduit apparatus comprising a catalyst return conduit and at least two flow control devices in series, each flow control device arranged to control the flow of fluid through the conduit, wherein the length of the catalyst return conduit is more than 20 m. A process for reacting a feedstock in a riser reactor system comprising a riser reactor, the catalyst return apparatus and, and a stage vessel, the process comprising: holding a fluid comprising the catalyst in the at least one stage vessel for a residence time of at least 10 seconds. | 2014-11-20 |
20140343339 | METHOD FOR OBTAINING OLEFINS FROM FURNACE GASES OF STEEL WORKS - The invention relates to a method for processing furnace gas ( | 2014-11-20 |
20140343340 | DEHYDROXYLATION OF POLYETHER POLYOLS AND THEIR DERIVATIVES USING A HALOGEN-BASED CATALYST - Polyether polyols, derivatives and combinations thereof are converted to olefins under reductive or non-reductive dehydroxylation conditions, in the presence of a halogen-based catalyst. Derivatives include polyether polyols incorporated in polyurethanes. The process includes gas pressure from 1 psig (˜6.89 KPa) to 2000 psig (˜13.79 MPa), a temperature from 50° C. to 250° C., a liquid reaction medium, and a molar ratio of the starting material to halogen atoms from 1:10 to 100:1. | 2014-11-20 |
20140343341 | PURIFICATION METHOD AND PURIFICATION SYSTEM FOR PROPANE - [PROBLEM] To provide an industrially advantageous method and system that are simple and have superior energy efficiency for obtaining high-purity propane from low-purity propane. | 2014-11-20 |
20140343342 | METHOD FOR REMOVAL OF RADIOACTIVE CESIUM AND FACILITY THEREFOR - To provide a method and an apparatus for removing radioactive cesium from waste containing radioactive cesium at low cost. A radioactive cesium removal apparatus | 2014-11-20 |
20140343343 | System and Method for Disposal of Mutagen Waste - An assembly and method for processing human waste includes providing a supporting base having an opening within which a waste reservoir is affixed. The assembly may be installed on or below a rim of a toilet bowl. Solidification and pathogen killing materials are provided. The materials are deposited in the reservoir either prior to or upon accumulation of waste in the reservoir. The reservoir with the solidified waste is then sealed and transported to a collection facility. | 2014-11-20 |
20140343344 | Radiation Therapy Guided Using Gamma Imaging - Radiation therapy of a lesion within a patient is guided to take into account movement of the lesion caused by respiration and/or cardiac effects by using MRI or other imaging system suitable for locating the lesion to image the patient while on the treatment support and using a gamma imaging system responsive to a radiation source preferentially taken up by the lesion and registered with the MRI so as to monitor movement of the lesion in real time and thus guide the beam of the RT. | 2014-11-20 |
20140343345 | Method for Fiducial-less Real-time Tracking in Radiation Treatment of Abdominal Tumors - A method for fiducial-less real-time motion tracking of abdominal tumors based on the correlation between the patient's breathing pattern and the diaphragm/lung border during treatment delivery. This invention utilizes an edge detection technique to delineate the diaphragm/lung border on radiographic images in order to calculate or determine tumor locations in the abdomen. The position of the diaphragm/lung border is synchronized with the breathing pattern obtained from continuous optical monitoring of a patient's respiratory cycle. The real-time optical breathing pattern obtained from monitoring is used to determine or calculate the position of the diaphragm/lung border during treatment delivery. The position of the diaphragm/lung border is then used to determine the tumor location in real-time. The target tumor coordinates generated through this process are used by the treatment delivery system to adjust the radiation beam geometry of the treatment delivery system to follow the tumor in real-time and accurately deliver radiation dose. | 2014-11-20 |
20140343346 | CHARGED PARTICLE BEAM IRRADIATION DEVICE - A charged particle beam irradiation device configured to irradiate a subject to be irradiated with a charged particle beam, including: an accelerator configured to accelerate charged particles and emit the charged particle beam; a gantry in which an irradiation unit for irradiating the subject with the charged particle beam is disposed; an irradiation table on which the subject is positioned; and a transportation line that includes an energy selection system for adjusting energy of the charged particle beam, and transport the charged particle beam to the irradiation unit from the accelerator. The transportation line is linearly formed up to the gantry from the accelerator, and at least a part of the energy selection system is disposed in the gantry, and a shield member configured to shield a radiation beam is provided between the energy selection system, which is disposed in the gantry, and the irradiation table. | 2014-11-20 |
20140343347 | METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER - A method of treatment and/or prevention of cancer comprises administering agents which cause increased intracellular granularity in cancer cells, at least in an amount sufficient to inhibit proliferation of such cells and preferably in an amount sufficient to lead to cancer cell death. The method is particularly directed to refractory cancer, particularly hormone refractory prostate cancer. The agents identified cause increased intracellular granularity in the cancer cells, and also convert adherent cancer cells to non-adherent cancer cells, leading to cancer cell death. Using the present invention, cancer cells undergo increased intracellular granularity at relatively low agent concentrations, while also inhibiting cell proliferation. Increased concentrations lead to conversion of adherent cancer cells to non-adherent cancer cells, then to cell death. While the exact mechanism of cancer cell degradation and death is not completely understood, the treated cancer cells, including refractory prostate cancer cells, give indications of cell death through an autophagic mechanism. Pharmaceutical compositions related to the presently disclosed methods are also disclosed. | 2014-11-20 |
20140343348 | METHODS AND DEVICES FOR DIAGNOSING, MONITORING, OR TREATING MEDICAL CONDITIONS THROUGH AN OPENING THROUGH AN AIRWAY WALL - Methods and devices for diagnosing, monitoring, and/or treating tissue through an opening or port through an airway wall. A passageway is created extending from the airway to the target tissue. The passageway provides local access to the target tissue for treatment instruments and for delivering agents. | 2014-11-20 |
20140343349 | COORDINATING EMERGENCY TREATMENT OF CARDIAC DYSFUNCTION AND NON-CARDIAC NEURAL DYSFUNCTION - Herein is described a device and methods-of-use to treat multiple possible causes of sudden neurological dysfunction related to cardiac, cerebrovascular, or brain electrical abnormalities. The device can be employed so as to treat cardiac dysfunction such as arrhythmia and subsequently related dysfunction of the central nervous system such as stroke and seizure. Alternatively, the device can be employed so as to treat cardiac dysfunction simultaneous with treatment of dysfunction of the central nervous system. Finally, the device can be employed so as to augment the effectiveness of treating cardiac dysfunction, namely the restoration of cardiac output and blood flow to the brain, by dilating the arteries of the brain. | 2014-11-20 |
20140343350 | INSTRUMENTED ORTHOPEDIC AND OTHER MEDICAL IMPLANTS - Medical implants can comprise various instrumentation to impart desirable functionality to the implant. In some embodiments, the implants comprise functional structures, such as sensors, energy propagating transducers, drug delivery systems and the like. Additional instrumentation to facilitate the functionality of these devices can include, for example, microprocessors, communication systems, power sources or the like. Drug delivery systems can comprise, for example, an isolated reservoir with a control system to control the delivery of a biological agent from the reservoir. The implants can be orthopedic implants that are designed to interface with a patient's skeletal system wherein the orthopedic implant may itself embody sensors, processors, power supplies, memory and/or communication capability. | 2014-11-20 |
20140343351 | TRANSCRANIAL MAGNETIC STIMULATION SYSTEM - A compact and economical transcranial magnetic stimulation system has a magnetic field generator for generating a magnetic field to be used for providing magnetic stimulation to the head of patient. The generator has a magnetic coil for generating a variable magnetic field and a holder for holding the magnetic coil. The holder has positioning portions for positioning the holder against respective markings on the head of patient. The coil is placed into a suitable posture against certain position by aligning the positioning portions with the markings on the head of patient. | 2014-11-20 |
20140343352 | ROTATIONAL PUMP AND METHODS FOR CONTROLLING ROTATIONAL PUMPS - A rotational pump capable of running at a rotational speed (n) having a system for direct or indirect measurement of pressure difference or flow rate across the pump, wherein a control system is designed to calculate an index of pulsatility (PI) of the pressure difference or flow rate, estimating the gradient of PI with respect to the rotational speed (dPI/dn) and regulating the dPI/dn to a pre-defined set-point or regulating the pump in a way that the dPI/dn is minimal. | 2014-11-20 |
20140343353 | Systems and Methods for Delivering Sensory Input During a Dream State - Embodiments of the invention provide apparatus, systems and methods for detecting neurological activity indicative of a dream state of a human. Many embodiments of the invention provide apparatus, systems and methods for detecting neurological activity of a human indicative of a dream state or the onset thereof and delivering an input to the user (such as an audio or other sensory input) during the dream state. Particular embodiments of the invention provide systems and methods for detecting neurological activity indicative of the onset or occurrence of a dream state of a human and delivering an audio or other sensory input during the user's dream state. The audio input may be used for learning, delivering messages to the user's subconscious, and/or promoting a state of relaxation. | 2014-11-20 |
20140343354 | BINAURAL SLEEP INDUCING SYSTEM - By using an iterative loop of data collection, binaural tone generation/presentation, and analysis binaural tones can be introduced to induce an existing brain state to change from one associated with being awake to a state associated with being asleep. The current state of an individual's brain is determined by measuring movement and electrical activity. Using this data a binaural tone can be generated to induce the brain state to change. As the state of the brain is continually monitored the applied binaural tone is modified and applied until the desired sleep state is obtained. | 2014-11-20 |
20140343355 | SACROCOLPOPEXY SUPPORT - A sacrocolpopexy support includes a Y-shaped body having a planar base and a pair of legs extending from the planar base, a first interconnecting member coupled to the planar base of the Y-shaped body, and an adjustable anchor coupled to and movable bi-directionally along the first interconnecting member. | 2014-11-20 |
20140343356 | THERAPEUTIC METHODS AND DEVICES FOLLOWING MYOCARDIAL INFARCTION - Described herein are methods of treating a patient to prevent or correct cardiac remodeling following myocardial infarction. In general these methods may include inserting or implanting a device in a heart chamber to support the affected region within 72 hours after myocardial infarction. The device may be a support device (e.g., a resilient frame) and/or a partitioning device. | 2014-11-20 |
20140343357 | SLOTTED CLEAR CANNULA - A slotted cannula for endoscopic surgical procedures is disclosed. The slotted cannula has a tubular body having a distal end, a proximate end, an open slot extending longitudinally from the beginning of the proximate end to the proximity of the distal end, and a pair of wings integrally formed on the proximate end. The tubular body is made from a transparent material and has an inner diameter large enough to accommodate an endoscope. | 2014-11-20 |
20140343358 | SECONDARY IMAGING ENDOSCOPIC DEVICE - Described herein are various detachable secondary imaging endoscopic devices that can be used in conjunction with an endoscope to provide additional fields of view so that multiple regions of a body cavity may be imaged simultaneously. In one variation, a secondary imaging endoscopic device comprises an endoscope attachment member configured to be disposed over an endoscope, a first imaging element and a corresponding first light source at a first location on the endoscope attachment member, and a second imaging element and a second light source at a second location that is adjacent to the first location. In some variations, a secondary imaging device comprises a fluid delivery module having one or more ports for fluid delivery. The multiple simultaneous images acquired by the secondary imaging endoscopic device imaging elements and the main endoscope imaging element can be combined or arranged together to form a continuous view of a body cavity. | 2014-11-20 |
20140343359 | CONTROL AND DISPLAY DEVICE - A device for display of medical vision images and video may include a portable display screen and housing. The device may also include a mounting mechanism located on the back of the housing. The mounting mechanism may be configured to removably engage a complementary mounting mechanism on a structure for removably mounting the portable display screen and housing to the structure. The device may also include means for communicatively coupling the portable display screen to one or more optoelectronic vision and illumination modules for control and processing of information. | 2014-11-20 |
20140343360 | RAPID LAPAROSCOPY EXCHANGE SYSTEM AND METHOD OF USE THEREOF - A system for positioning an interchangeable tool in a body cavity includes a channel having a lumen in direct communication with the body cavity; a tool introducer having a longitudinal axis and a distal end, the tool introducer capable of traveling through the channel lumen; and a tool holder covering at least a portion of the interchangeable tool that is pivotally connected to the tool introducer allowing angular positioning of the interchangeable tool after the tool holder emerges from the channel into the body cavity. A method for engaging an interchangeable tool with a distal portion of a tool manipulator in a body cavity includes inserting a tool introducer into a channel, orienting the distal portion of the tool manipulator in the body cavity; emerging the interchangeable tool from the channel into the body cavity; and positioning the interchangeable tool eccentrically to the lumen of the channel. | 2014-11-20 |
20140343361 | Tip Protector for a Multi-Viewing Elements Endoscope - A tip protector for a multiple viewing element endoscope is provided, that protects the front as well as side viewing elements in the tip. In one embodiment, the protector comprises wings that act as shock absorbers. The protector is further designed such that the endoscope can washed without having to remove the protector from the tip. | 2014-11-20 |
20140343362 | HIGHLY CORRECTED RELAY SYSTEM - A highly corrected relay system for medical endoscopes or the like is provided. The system includes a plurality of bonded lenses that are selected to provide color correction from the blue region of the spectrum through to the near infrared region of the spectrum. The system allows co-located visible and near infrared images to be resolved on a single detector. | 2014-11-20 |
20140343363 | SURGICAL ACCESS SYSTEM AND RELATED METHODS - A surgical access system including a tissue distraction assembly and a tissue refraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site. | 2014-11-20 |
20140343364 | WOUND RETRACTOR - A retraction device for retracting an incision in a body wall includes a sheath that traverses through the incision from outside the body to a body cavity inside the body. The retraction device may include a deployable, adjustable frame that supports the sheath and that, together with the sheath, retracts the incision. The retraction device may include an outer ring and an inner ring coupled to opposing ends of the sheath and further include means to place the sheath in tension between the inner and outer rings, thereby retracting the incision. | 2014-11-20 |
20140343365 | Laparoscopic Seal Bridge - A system and method for passing an end portion of a needle system from a body cavity to an outer environment through a laparoscopic port is provided. The system comprises a seal bridge which comprises an elongated body. The seal bridge is telescopically introducible at a first proximal end, through a first lumen in the port and bypassing a seal mechanism of the laparoscopic port. The seal bridge is adapted to be inserted through the proximal opening port to be deployed in the lumen of the port and thereby bridging across and/or deactivating the seal of the port. The method comprises positioning a distal portion of a needle shaft from within the body cavity into the port lumen and across the seal opened by the seal bridge. | 2014-11-20 |
20140343366 | METHODS AND APPARATUS FOR REDUCING THE RISK OF SURGICAL SITE INFECTIONS - A surgical access system that facilitates access to a surgical site through an incision in the patient's body includes a surgical retractor and a fluid delivery or fluid evacuation device. The fluid delivery or fluid evacuation device is coupled to the surgical retractor and is adapted to deliver fluid to the surgical site or evacuate fluid from the surgical site. | 2014-11-20 |
20140343367 | VESSEL RETRACTOR - A surgical apparatus includes an elongated cannula having an external sidewall surface and a lumen extending between a cannula proximal regional and a cannula distal region, the cannula is further configured to receive an endoscope, and has a handle located at the cannula proximal region, a first wire extending from the cannula distal region and adapted to slide longitudinally with respect to the cannula in both a distal and proximal direction via a control at the handle, and a ring connected to the first wire. The ring has a curved surface with concavity hollowed towards a region of the cannula configured to receive the endoscope. | 2014-11-20 |
20140343368 | Apparatus and Method for removing a foreign object from a rectal cavity - A new and useful apparatus and method are provided for removing a foreign object from a rectal cavity. An anoscope is configured for insertion through the anus into a rectal cavity. The anoscope has a base and introducer with guides that route flexible members and a flexible sheath that are carried by actions of the operator through the anoscope beyond the guide and further into a rectal cavity and to expand about a foreign object in the rectal cavity. The anoscope also carries a noose that is manipulatable from outside the patient's rectal cavity to tighten and stricture the flexible sheath above the foreign object and capture the foreign object within the flexible sheath, so that the foreign object can be manipulated by the noose and the flexible sheath to remove the foreign object from the rectal cavity once the anoscope and flexible ribs are removed from the anus. | 2014-11-20 |
20140343369 | OPERATION-MODE INDICATING SYSTEM FOR BODY SUPPORT APPARATUS, AND BODY SUPPORT APPARATUS - In an operation-mode indicating system, a first light emitting device is located within a peripheral visual field of an operator and is controllably connected to a controller. The peripheral visual field is defined around a center visual field of the operator while the operator is looking at a predetermined site. A body support apparatus is capable of performing an operation to the predetermined site. The controller controls the first light emitting device to emit first light in a first operation mode of the body support apparatus and second light in a second operation mode of the body support apparatus. The first light and the second light are visually distinguishable from each other. | 2014-11-20 |
20140343370 | METHOD AND APPARATUS FOR PROVIDING DERVIED GLUCOSE INFORMATION UTILIZING PHYSIOLOGICAL AND/OR CONTEXTUAL PARAMETERS - Systems and methods for non-invasively determining parameters related to blood glucose are disclosed. Embodiments are disclosed wherein a wearable sensor device comprises non-invasive sensors generating various sensed data which is then utilized to determine a glucose-related parameter. | 2014-11-20 |
20140343371 | WEARABLE SENSOR DEVICE FOR HEALTH MONITORING AND METHODS OF USE - A device for monitoring health information. The device comprises a material capable of being worn on a person's body, an optical generator, an optical sensor, a processor, and an interface for communicating with an external device. The device may also include two EKG sensors. The device non-invasively monitors a variety of health characteristics and transmits the health data to a base station such as a smartphone. The base station includes a software application that can display, store, and analyze the user's health data. The user may review his health information on the base station's display. In an alternative embodiment, the base station transmits the health data to a secure remote server. The user may review his health information on a website associated with the remote server. | 2014-11-20 |
20140343372 | AUTOMATIC LOCATION DETECTION OF A PHYSIOLOGICAL MEASUREMENT SYSTEM ON A USER'S BODY - Embodiments provide physiological measurement systems, devices and methods for continuous health and fitness monitoring. A wearable strap may detect reflected light from a user's skin, where data corresponding to the reflected light is used to automatically and continually determine a heart rate of the user. Based on signals associated with the user's heart rate, the system may detect the location of the wearable strap on the user's body, and then adjust its analysis of the reflected light data to determine the heart rate of the user. | 2014-11-20 |
20140343373 | Oral Cavity Sensor - To propose an oral cavity sensor capable of analyzing tongue movements in more detail than before. In an oral cavity sensor ( | 2014-11-20 |
20140343374 | LOW PROFILE TEMPERATURE TRANSDUCER - A low profile temperature transducer has a working surface for placement against a body surface and a first output. The transducer is a flat laminate composed of alternating conductive and dielectric layers. The laminate defines at least one slotline antenna for exposure to the body surface to pick up thermal emissions from the underlying tissue at depth. A feed network having a characteristic impedance is connected to the first output and a slotline-to-stripline transition is connected between the at least one antenna and the feed network, the transition providing a match between the impedance at the at least one antenna and the characteristic impedance. Also, a temperature sensor may be present at the working surface to detect the body surface temperature under the transducer, that surface temperature being used to calculate actual temperature at depth. | 2014-11-20 |
20140343375 | METHOD AND CIRCUIT FOR STORING AND PROVIDING HISTORICAL PHYSIOLOGICAL DATA - Embodiments of the present invention include systems and methods that relate to pulse oximetry. Specifically, one embodiment includes an oximeter sensor comprising a light emitting element configured to emit light, a light detector configured to detect the light, and a memory chip having a built-in trimmed resistor, the trimmed resistor having a resistance value that is detectable by a monitor. | 2014-11-20 |
20140343376 | PREDICTIVE DIAGNOSIS OF A PATIENT'S STATUS IN AN ACTIVE IMPLANTABLE MEDICAL DEVICE NOTABLY FOR CARDIAC PACING, RESYNCHRONIZATION, DEFIBRILLATION OR CARDIOVERSION - An active implantable medical device, notably a device for pacing, resynchronization defibrillation and/or cardioversion, and/or a device for diagnosing patient conditions, having a predictive diagnosis of the patient's status. The device measures a physiologic parameter, notably the minute ventilation (MV); measures a physical parameter, notably the acceleration (G); discriminates between phases of activity and rest of the patient; and includes a memory containing a plurality of fields selectively updated by statistical processing. These fields are comprising one first set ( | 2014-11-20 |
20140343377 | PORTABLE DEVICE FOR MEASURING BLOOD PRESSURE AND METHOD THEREOF - A portable blood pressure measuring apparatus and a method therefor are provided. A method for measuring blood pressure by an electronic device includes measuring a blood pressure of a user; measuring a Pulse Wave Velocity (PWV) using a pulse wave and an ElectroCardioGram (ECG) signal of the user, wherein the pulse wave is measured by an optical sensor, and the ECG signal is measured by an ECG electrodes portion; and compensating the blood pressure using the PWV. | 2014-11-20 |
20140343378 | SYSTEM AND METHOD FOR ACOUSTIC INFORMATION EXCHANGE INVOLVING AN INGESTIBLE LOW POWER CAPSULE - A method of communicating with an ingestible capsule includes detecting the location of the ingestible capsule, focusing a multi-sensor acoustic array on the ingestible capsule, and communicating an acoustic information exchange with the ingestible capsule via the multi-sensor acoustic array. The ingestible capsule includes a sensor that receives a stimulus inside the gastrointestinal tract of an animal, a bidirectional acoustic information communications module that transmits an acoustic information signal containing information from the sensor, and an acoustically transmissive encapsulation that substantially encloses the sensor and communications module, wherein the acoustically transmissive encapsulation is of ingestible size. The multi-sensor array includes a plurality of acoustic transducers that receive an acoustic signal from a movable device, and a plurality of delays, wherein each delay is coupled to a corresponding acoustic transducer. Each delay may be adjusted according to a phase of a signal received by the corresponding acoustic transducer. | 2014-11-20 |
20140343379 | METHOD AND DEVICE FOR MONITORING OPHTHALMIC LENS MANUFACTURING CONDITIONS - A method and communication system for ophthalmic device manufacturing line is disclosed. More specifically, the communication device may be incorporated in early stages of manufacturing of the ophthalmic device to monitor process controls without delay. In some embodiments, a unique pedigree profile can be stored for an ophthalmic device during manufacturing and correlated with one or more of: design profiles, controlled process parameters, performance, and distribution channels. | 2014-11-20 |
20140343380 | Correlating Sensor Data Obtained from a Wearable Sensor Device with Data Obtained from a Smart Phone - Sensor data obtained from a wearable sensor device can be correlated with sensor data obtained from a smart phone or other mobile device. The correlation of the data from the two sources can enable the determination of why a person performs some action during sleep. In a particular example, motion data obtained from a wearable sensor device can be correlated with audio or visual data obtained by a sensor on a smart phone. In this way, it can be determined whether a person moved in response to a sound or light perceived during sleep. Additionally, the correlation of the data from the two sources can also provide additional information about how a user performs an activity such as exercise. | 2014-11-20 |
20140343381 | OPACITY CONSISTENT POLYMER GRAFT FOR OPTICAL SENSOR - A sensor (e.g., an optical sensor) that may be placed within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid) within the animal. The sensor may include a sensor housing and a polymer graft including indicator molecules and covering at least a portion of the sensor housing. The opacity of the polymer graft may remain substantially the same (i.e., may have little or no variation) over time. The sensor may include a photodetector, and variation in the opacity of the polymer graft does not cause a significant change in a measurement signal output by the photodetector. The polymer hydrogel may be made of polymers including acrylic acid and/or polyethylene glycol. | 2014-11-20 |
20140343382 | Methods And Systems For Using A Thermistor In Probe Identification Circuits In Or Associated With Pulse Oximeter Sensors - Provided according to embodiments of the present invention are pulse oximetry systems that include a pulse oximeter sensor, and a probe identification circuit that includes a thermistor. The probe identification circuit may be part of or associated with the pulse oximeter sensor. | 2014-11-20 |
20140343383 | MEASUREMENT DEVICE, MEASUREMENT METHOD, PROGRAM AND RECORDING MEDIUM - A measurement device according to the present disclosure includes a light source which emits at least one kind of measurement light belonging to a predetermined wavelength band toward a measurement region formed of at least part of a living body, a detection unit in which a plurality of sensors is regularly arranged in a predetermined arrangement and which detects the measurement light emitted from the light source and passing through the living body with the plurality of sensors, and an analysis unit which performs analysis processing of specifying a measurement position for measuring information on pulsation along with activities of the living body from the measurement region based on a temporal change in an amount of light of the detected measurement light by use of a detection result detected by the detection unit. | 2014-11-20 |
20140343384 | FIBER OPTIC FLOW AND OXYGENATION MONITORIONG USING DIFFUSE CORRELATION AND REFLECTANCE - Disclosed are fiber optic devices and related methods that allow for measurement of blood flow and oxygenation in real time. These devices have particular application to the spinal cord. Such devices have applicability in, for example, the care of military members sustaining combatant and noncombatant spinal injuries, as well as to civilians. The devices also have utility in the acute and subacute management of spine trauma, enhancing the efficacy of interventions aimed at the prevention of secondary ischemic injury, and ultimately improving neurologic outcome. | 2014-11-20 |
20140343385 | METHOD FOR ENHANCING PULSE OXIMETRY CALCULATIONS IN THE PRESENCE OF CORRELATED ARTIFACTS - Methods and systems for determining a physiological parameter in the presence of correlated artifact are provided. One method includes receiving two waveforms corresponding to two different wavelengths of light from a patient. Each of the two waveforms includes a correlated artifact. The method also includes combining the two waveforms to form a plurality of weighted difference waveforms, wherein the plurality of weighted difference waveforms vary from one another by a value of a multiplier. The method further includes identifying one of the weighted difference waveforms from the plurality of weighted difference waveforms using a characteristic of one or more of the plurality of weighted difference waveforms and determining a characteristic of the correlated artifact based at least in part on the identified weighted difference waveform. | 2014-11-20 |
20140343386 | CONTINUOUS ANALYTE SENSORS AND METHODS OF MAKING SAME - Described here are embodiments of processes and systems for the continuous manufacturing of implantable continuous analyte sensors. In some embodiments, a method is provided for sequentially advancing an elongated conductive body through a plurality of stations, each configured to treat the elongated conductive body. In some of these embodiments, one or more of the stations is configured to coat the elongated conductive body using a meniscus coating process, whereby a solution formed of a polymer and a solvent is prepared, the solution is continuously circulated to provide a meniscus on a top portion of a vessel holding the solution, and the elongated conductive body is advanced through the meniscus. The method may also comprise the step of removing excess coating material from the elongated conductive body by advancing the elongated conductive body through a die orifice. | 2014-11-20 |
20140343387 | OPHTHALMIC LENS WITH A MICROFLUIDIC SYSTEM - The present invention described a system for an energized ophthalmic device with a media insert that includes microfluidic elements upon or within the media insert. In some embodiments, the microfluidic elements may be useful for the purpose of analyzing an analyte such as glucose in a fluid sample. In addition, some embodiments can function with a medicament administering device to treat an abnormal condition identified during the analyte analysis in the fluid sample. | 2014-11-20 |
20140343388 | Representation and identification of activity patterns during electro-physiology mapping using vector fields - A method and system for mapping an anatomical structure includes sensing activation signals of intrinsic physiological activity with a plurality of mapping electrodes disposed in or near the anatomical structure, each of the plurality of mapping electrodes having an electrode location. A vector field map which represents a direction of propagation of the activation signals at each electrode location is generated to identify a signature pattern and a location in the vector field map according to at least one vector field template. A target location of the identified signature pattern is identified according to a corresponding electrode location. | 2014-11-20 |
20140343389 | Wireless Monitoring Device - The present invention relates to a monitor and monitoring system suitable for attachment to the skin of a mammal, including a human. The monitor and monitoring system are designed for continuous wireless real-time measurement of physiological signals and transmission of the measurements to a remote computer or mobile device. | 2014-11-20 |